Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current Complementary and Alternative Therapies for Multiple Sclerosis.

Allen C. Bowling1, Thomas M. Stewart

  • 1Complementary and Alternative Medicine Program, Rocky Mountain Multiple Sclerosis Center, 701 East Hampden Avenue, #530, Englewood, CO 80110, USA. bowling@mscenter.org

Current Treatment Options in Neurology
|January 11, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Visual Impairment and Driving in Older Adults: A Narrative Review.

Current treatment options in neurology·2026
Same journal

Non-Cognitive Symptoms in Alzheimer's Disease and Their Likely Impact on Patient Outcomes. A Scoping Review.

Current treatment options in neurology·2026
Same journal

Update on the Treatment of Autonomic Disorders.

Current treatment options in neurology·2025
Same journal

Primary Progressive Aphasia Treatment: Current Treatment Options in Neurology Article Topic: Management of Primary Progressive Aphasia.

Current treatment options in neurology·2025
Same journal

Emerging Principles for Treating Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD).

Current treatment options in neurology·2025
Same journal

Diagnosis and Management of Progressive Corticobasal Syndrome.

Current treatment options in neurology·2025
See all related articles

Many patients with multiple sclerosis (MS) use complementary and alternative medicine (CAM). While some CAM therapies show mild benefits for MS, definitive evidence of effectiveness is lacking, necessitating cautious discussion with healthcare providers.

Area of Science:

  • Neurology
  • Immunology
  • Nutritional Science

Background:

  • Complementary and alternative medicine (CAM) use is prevalent among the general population and individuals with multiple sclerosis (MS).
  • Conventional treatments for MS often have limitations, driving patient interest in alternative approaches.
  • Understanding the efficacy and safety of CAM in MS management is crucial.

Purpose of the Study:

  • To review the current evidence on the effectiveness and safety of various complementary and alternative medicine (CAM) therapies for multiple sclerosis (MS).
  • To inform healthcare providers about the potential benefits and limitations of CAM for MS patients.

Main Methods:

  • Systematic review of existing literature on diets, dietary supplements, and other CAM interventions in MS.

Related Experiment Videos

  • Analysis of clinical trial data and preclinical studies investigating immunomodulatory and therapeutic effects of specific compounds.
  • Evaluation of safety information and evidence for disease-modifying capabilities.

    • Main Results:

    • No diets or supplements are definitively effective in altering MS disease course, though polyunsaturated fatty acids may offer mild benefits.
    • Compounds like Vitamin D, ginkgo biloba, cannabinoids, and Padma 28 show promise in experimental models but lack sufficient clinical data.
    • Evidence supporting vitamin B12 supplementation or gluten-free diets for MS is absent; the role of antioxidants remains unclear.

    Conclusions:

    • CAM therapies, while often inexpensive and safe, lack definitive efficacy for altering MS progression, limiting physician interest but maintaining patient appeal.
    • Further clinical trials are needed to validate the therapeutic potential and safety of specific CAM interventions in MS.
    • Healthcare providers should engage in open discussions about CAM, providing objective, MS-relevant information to patients.